Guselkumab
Tremfya (guselkumab) is an antibody pharmaceutical. Guselkumab was first approved as Tremfya on 2017-07-13. It is used to treat psoriasis in the USA. It has been approved in Europe to treat psoriasis.
| Trade Name | Tremfya |
|---|---|
| Common Name | Guselkumab |
| Indication | psoriasis |
| Drug Class | Monoclonal antibodies: fully human, interleukins as target |
